The House Resolution urges the Louisiana Attorney General and the Department of Insurance to investigate pharmacy benefit managers (PBMs) for potential legal violations. It highlights the significant influence PBMs have over drug pricing and reimbursement rates, which can disadvantage independent pharmacies and lead to higher costs for patients. The resolution references alarming trends in other states where patients have paid more for medications through insurance than if they had paid cash, indicating systemic issues with PBM practices. It also notes the detrimental effects of PBM ownership of pharmacies, which can create conflicts of interest and threaten the viability of community pharmacies, particularly in rural areas.

Furthermore, the resolution calls for the Louisiana legislature to enact laws prohibiting PBMs from owning or having financial interests in pharmacies. It emphasizes the need for transparency and fairness in pharmaceutical reimbursement practices to protect consumer choice and ensure access to medications. The resolution reflects a growing concern about the consolidation of PBMs and their impact on healthcare delivery, particularly for underserved populations, and seeks to promote policies that support independent pharmacies and prevent market abuses.